The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of global histone modifications to predict response to gemcitabine in patients with pancreatic cancer.
Takuo Watanabe
No relevant relationships to disclose
Soichiro Morinaga
No relevant relationships to disclose
Makoto Akaike
No relevant relationships to disclose
Masakatsu Numata
No relevant relationships to disclose
Hiroshi Tamagawa
No relevant relationships to disclose
Naoto Yamamoto
No relevant relationships to disclose
Manabu Shiozawa
No relevant relationships to disclose
Shinichi Ohkawa
No relevant relationships to disclose
Kameda Yoichi
No relevant relationships to disclose
Yoshiyasu Nakamura
No relevant relationships to disclose
Munetaka Masuda
No relevant relationships to disclose
Yohei Miyagi
No relevant relationships to disclose